We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
+9.86%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$27.9B
AUM Growth
+$6.35B
Cap. Flow
+$3.76B
Cap. Flow %
13.48%
Top 10 Hldgs %
12.67%
Holding
2,368
New
371
Increased
836
Reduced
637
Closed
381

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$228M
2
KO icon
Coca-Cola
KO
+$167M
3
AAPL icon
Apple
AAPL
+$131M
4
MDLZ icon
Mondelez International
MDLZ
+$121M
5
UNH icon
UnitedHealth
UNH
+$116M

Sector Composition

Rank Sector Weight
1 Technology 19.75%
2 Healthcare 15.02%
3 Consumer Discretionary 12.4%
4 Financials 11.54%
5 Industrials 11.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBNC icon
1701
Horizon Bancorp
HBNC
$1.03B
$163K ﹤0.01%
+10,800
New +$178K
ROVR
1702
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$162K ﹤0.01%
44,265
+365
+0.8% +$1.56K
OPTU
1703
Optimum Communications Inc
OPTU
$316M
$160K ﹤0.01%
34,843
-12,336
-26% -$60.6K
PUBM icon
1704
PubMatic
PUBM
$581M
$159K ﹤0.01%
+12,400
New +$194K
CERS icon
1705
Cerus
CERS
$587M
$159K ﹤0.01%
43,476
-5,700
-12% -$21.5K
SLGC
1706
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$158K ﹤0.01%
+63,078
New +$176K
TAC icon
1707
TransAlta
TAC
$4.34B
$156K ﹤0.01%
17,500
+1,800
+11% +$16.1K
CNCE
1708
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$156K ﹤0.01%
+26,769
New +$141K
KG
1709
Kestrel Group
KG
$71.3M
$156K ﹤0.01%
3,701
+2,779
+301% +$118K
PEB icon
1710
Pebblebrook Hotel Trust
PEB
$2.16B
$155K ﹤0.01%
+11,606
New +$177K
BKSY icon
1711
BlackSky Technology
BKSY
$800M
$154K ﹤0.01%
+12,511
New +$167K
JELD icon
1712
JELD-WEN Holding
JELD
$94.8M
$154K ﹤0.01%
+15,936
New +$155K
ZVRA icon
1713
Zevra Therapeutics
ZVRA
$563M
$152K ﹤0.01%
33,046
+3,768
+13% +$19.1K
ASRT
1714
DELISTED
Assertio
ASRT
$149K ﹤0.01%
+2,311
New +$102K
CGNT icon
1715
Cognyte Software
CGNT
$612M
$149K ﹤0.01%
47,771
+20,271
+74% +$59.5K
NNOX icon
1716
Nano X Imaging
NNOX
$62.4M
$149K ﹤0.01%
20,125
+899
+5% +$9.96K
CBAY
1717
DELISTED
Cymabay Therapeutics
CBAY
$147K ﹤0.01%
+23,469
New +$89.2K
PSTX
1718
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$147K ﹤0.01%
27,663
+15,647
+130% +$71.5K
SCPH
1719
DELISTED
scPharmaceuticals
SCPH
$146K ﹤0.01%
+20,430
New +$125K
ARC
1720
DELISTED
ARC Document Solutions, Inc.
ARC
$145K ﹤0.01%
49,603
+33,116
+201% +$87.8K
PDSB icon
1721
PDS Biotechnology
PDSB
$38.1M
$145K ﹤0.01%
+10,988
New +$77.5K
LYTS icon
1722
LSI Industries
LYTS
$853M
$145K ﹤0.01%
+11,830
New +$118K
CENX icon
1723
Century Aluminum
CENX
$4.57B
$145K ﹤0.01%
+17,677
New +$134K
ZYME icon
1724
Zymeworks
ZYME
$1.68B
$144K ﹤0.01%
18,289
-142,256
-89% -$1,000K
BMEA icon
1725
Biomea Fusion
BMEA
$90.4M
$143K ﹤0.01%
+16,969
New +$145K

Similar funds

Man Group's Q4 2022 Portfolio in Review

As of Q4 2022, Man Group held 2,368 positions worth $27.9B, up 29% from $21.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Man Group deployed $3.76B of net new capital in Q4 2022, opening 371 new positions and adding to 836 existing holdings. Its largest new stake was Textron: 910,556 shares worth $64.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Public Storage, an estimated $80.2M trimmed.

  • Man Group's largest Q4 2022 buy was Textron: 910,556 shares worth $64.5M.
  • Man Group added most to PepsiCo in Q4 2022, an estimated $228M increase.
  • Man Group's biggest Q4 2022 reduction was Public Storage, cutting an estimated $80.2M.
  • Man Group fully exited ZENDESK INC in Q4 2022, selling an estimated $69.1M.
  • Man Group's ten largest holdings make up 13% of its $27.9B portfolio in Q4 2022.
  • Man Group opened 371 new positions and closed 381 in Q4 2022.
  • Man Group's portfolio value rose 29% quarter-over-quarter to $27.9B.

Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.